MedTrace Logo

Heart Failure Precision Medicine Study

NCT04196842 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-02-09

No results posted yet for this study

Summary

The study aims to test the hypothesis that multi-omics studies can identify Heart Failure profiles at risk of adverse outcomes and evaluate a telemonitoring intervention in the optimization of guideline-directed medical therapy.

Conditions

Interventions

DEVICE

Telemonitoring devices

Set of telemonitoring devices: heart rate and blood pressure monitor, scale and activity tracker.

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Martin Cadeiras, MD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-16
Primary Completion
2026-10-16
Completion
2026-10-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04196842 on ClinicalTrials.gov